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Abstract
We have shown previously that, m rats with deoxycortlcosterone (DOC)-salt hypertension, arterial blood pressure rises more rapldly and reaches a higher level m male than m female rats and that the course of the hypertension was amehorated by gonadectomy m male rats and exacerbated by gonadectomy m female rats The present mvestigatlon was undertaken to examme the role of the gonadal steroid hormones m modulating the course of DOC-salt hypertension m the rat Our previous findings with respect to the effects of gender and gonadectomy on DOC-salt hypertension were confirmed m this study Chronic treatment with gonadal steroids was begun 1 week before the start of the DOC-salt protocol 17P-Estradlol attenuated the course of the hypertension m intact male rats and m gonadectormzed females Testosterone exacerbated the development of the hypertenslon m gonadectomlzed male rats but was without effect m intact females Progesterone alone had no effect on the hypertension m ovartectomlzed rats but when given to ovarlectonuzed rats m combmation with estrachol transiently prevented the amehorating effect of the estradlol. These effects of the gonadal steroid hormones could not be attributed to effects of salme intake Thus, these findings demonstrate that the gonadal steroid hormones play an important role m modulating the pathogenesis of DOCsalt hypertension m the rat It 1s suggested that the effects of the gonadal hormones on the course of the hypertension may be due to modulation of the cardiovascular and renal actions of vasopressm, Since vasopressm 1s required for this model of hypertension (Hypertenszon. 1997; 29[part 2]:494-499.) Key Words l gender differences l sex steroids l DOCsalt hypertenvlon T he Incidence of hypertension 1s higher m men than m premenopausal women. 1 Snmlarly, we have shown that the development of deoxycorticosterone (DOC)-salt hypertension 1s sexually dlmorphlc. Thus, the rate of increase m arterial blood pressure and the level to which it rises are greater m male than m female rats 2-1 It IS hkely that these differences are due to the actions of the gonadal steroid hormones, smce gonadectomy attenuated the hypertension m male rats and exacerbated it m females.4 The role of the mdlvldual gonadal steroid hormones m the hypertensive processes, however, has not been characterized The expenments presented here were undertaken to deal with this issue We have determmed m male and female rats the effect of gonadectomy, with and without gonadal steroid hormone treatment, on the development of DOC-salt hypertension. We have also determmed the effects of treatment of intact male rats with estradlol and intact female rats with testosterone.
Methods
Male and female Sprague-Dawley rats were gonadectonuzed or sham gonadectonuzed by the supplier (Harlan Sprague Dawley, IndIanapolls, Ind) when they were 3 weeks old They were shipped to us at age 4 to 5 weeks and were housed m animal quarters with controlled hghtmg (10 hours on, 14 hours off) and temperature (23°C to 24"C) The rats were given food (Purina Laboratory Chow) and tap water ad hbltum When the rats were 7 to 8 weeks old, they were umlaterally nephrectomlzed under ether anesthesia At that time they were given a subcutaneous From the Department of Physiology and Blophy~ics, Utnverslty of Tennessee, Memphis
Correspondence to Joan T Crofton, Department of Physiology and Blophyslcs, Umverslty of Tennessee, Memphis, 894 Union Ave. Memphis, TN 38163 E-mad Jcrofton@phys~ol utmem edu 0 1997 American Heart Associatton, Inc implant of gonadal steroid-containing slow-release pellets (Innovative Research of America) Gonadectomlzed males were given testosterone (10 mg) or a cholesterol placebo (10 mg). Gonadectormzed females were given 17&estrachol (0 5 mg), progesterone (10 mg), 17@estrachol (0 5 mg) plus progesterone (10 mg), or a cholesterol placebo (10 mg) Intact males were given 17P-estradlol (0 5 mg) or a cholesterol placebo (10 mg), and Intact females were given testosterone (10 mg) or a cholesterol placebo (10 mg) These doses of estrachol and progesterone m ovariectonnzed rats would provide plasma concentrations of estradlol that were approximately 4 times those seen m proestrus and concentrations of progesterone snmlar to those m proestruss, the dose of testosterone m gonadectonnzed males would result m plasma testosterone levels similar to those m intact males (communication from Innovative Research of America). One week later, the rats were divided mto two groups One group was given weekly subcutaneous mJectlons of DOC (Percorten Plvalate, Cuba, 30 mg/kg), and 1% saline replaced the drmkmg water The rats m the second group continued to drmk tap water and were given weekly subcutaneous mJections of 0 9% NaCl (1 2 mL/kg) as the vehicle for the DOC One week after unilateral nephrectomy and at weekly intervals thereafter, systolic blood pressure @BP) was measured by ta11 plethysmography, using a Physlograph SIX-B (Narco Biosystems) Durmg this procedure, the rats were hghtly anesthetized with ether and rested on a shghtly warmed heatmg pad After the measurement of SBP at week 1, the steroid pellets were removed and replaced with fresh pellets Flmd intake was measured for the 24-hour penod that preceded each weekly measurement of SBP Body weight was measured Just before each measurement of SBP The data were analyzed by one-way and two-way analyses of variance Where appropriate, significant differences were isolated by the Fisher LSD test Data are presented as mean+SEM
Results
In rats treated with DOC and given a salt supplement, SBP increased more rapldly and to a higher level (P< 01) m males than m females (Fig 1) Thus, by the end of the first week of treatment, SBP had mcreased slgmficantly (P< 01) m males but was unchanged m females At the end of weeks 2 and 3, the increases m SBP m male rats was approximately twice those m females (P< 05 to 01). Castration of males treated with DOC and salt greatly attenuated the course of the hypertension (P< 05 to .Ol>, which remamed similar to that seen m intact DOC-salttreated females (Fig 1) Treatment of gonadectomlzed males with testosterone restored the development of the hypertension to levels slmllar to those m intact males (Fig  2) , but this effect did not become apparent until the third week of the expenment.
In female rats, ovanectomy greatly enhanced the development of DOC-salt hypertension (Fig 1, P< 05 to 01) Indeed, by the end of 3 weeks of treatment with DOC and salt, the increase m SBP was similar to that m intact DOC-salt males When DOC-salt-hypertensive ovanectomlzed rats were treated with estradlol, the increases m SBP were reduced to levels slmllar to those m intact DOCsalt-hypertensive females, whereas treatment with progesterone did not alter the course of the hypertension m ovariectomlzed rats (Fig 3) . When ovariectomlzed DOC-salt rats were given both progesterone and estradlol, the progesterone prevented the amehoratmg action of estradlol on the development of hypertension for the first 2 weeks, but m the third week of the hypertension, SBP was at a level similar to that m the intact DOC-salt-hypertensive females (Fig 3) Treatment of intact males, given DOC and salt, with estradlol reduced the development of the hypertension to levels slmllar to those seen m gonadectomlzed hypertensive males (Fig 2) On the other hand, when intact DOCsalt-hypertensive females were treated with testosterone, there was no significant effect on the course of the hypertension (Fig 3) All male rats treated with the vehicle for DOC and given tap water to drmk (Table 1) (P< 01) in the first week of this treatment m the intact females given testosterone In intact male and female rats, fluid intake corrected for body weight (Table 2) was mcreased twofold to threefold by treatment with DOC and substltutlon of salme foi drmkmg water (P<.Ol), and there were no differences between males and females In rats treated with DOC and drinking saline, gonadectomy m males and females, treatment of gonadectomlzed males and intact males with testosterone, and treatment of ovarlectomlzed rats with pro-? OStsSI *PC 01 compared w& control (w&'C) -gesterone were wtthout effect on saline Intake, compared wtth intact hypertensive rats (Table 2 ). On the other hand, treatment of gonadectomrzed females and intact males with estradiol caused a further increase m salme intake (P< 01). During the first 2 weeks of observation, salme mtake m hypertensive ovariectomrzed rats treated with both estradtol and progesterone was stmtlar to that m ovartectomrzed hypertensive rats treated with estradtol alone, but m the thud week of observation, salme intake m the ovarrectomtzed rats treated with both estradtol and progesterone fell toward levels seen m ovartectomtzed rats that were untreated or given only progesterone (Table 2) . Gonadectomy resulted m an increase m body weight m females (Fig 4) Thts effect was reversed by treatment with estradrol Treatment of intact females with testosterone (Fig 4) resulted m small but significant increases m body weight (P< 01). In intact male rats, treatment with estradlol reduced body wetght (Fig 5, P< 01) 
Discussion
We had found prevtously that in rats treated with DOC and given saline to drink, arterial pressure rises faster and to a higher level m male than m female rats2-4 and that gonadectomy attenuated the development of hypertension m male rats and exacerbated tt m female rats 4 This suggested that the gonadal steroid hormones can affect the course of thu model of hypertension The findings m the present report indicate that this is Indeed the case Thus, m DOC-salt-hypertensive rats, the effects of gonadectomy were reversed by chromcally treating males with testosterone and females with estradtol Addmonally, chronic treatment of intact male DOC-salt-hypertensive rats with estradtol retarded the development of the hypertension Stmrlarly, tt has been observed that estrogen treatment attenuated the hypertension m cockerels made hypertensive by treatment with DOC and salt6 and m the spontaneously hypertensive rat,'.8 whereas testosterone treatment mcreased the hypertension m the spontaneously hypertensive rat 9 In contrast to these findings, Bunag'a has reported that pretreatment of female rats with Enovtd, a mixture of mestranol and norethynodrel, exacerbated DOC-salt hypertension It 1s difficult to explam this report m the light of the findings reported here and by others
The effects of gonadectomy and of testosterone and estradtol on the hypertension m the present experiments could not be due to differences m saline intake Testosterone was without effect on saline intake. Estradtol mcreased saline intake, but this would be expected to mcrease the hypertension rather than decrease tt, as observed m these experiments
The mechanisms by which estrogen and testosterone affect the development of DOC-salt hypertensron are, however, uncertain There are receptors for androgen and estrogen m centers m the brain stem involved m blood pressure regulation IL** Since there is considerable evrdence that the sympathetic nervous system 1s an Important pathogenetrc factor m DOC-salt hypertension, 13-16 the gonadal steroid hormones could act at these centers to modulate the acttvrty of the sympathetic nervous system Consistent with this posstbibty IS our observatron" that the sensitivity of the heart rate component of the baroreceptor reflex is reduced to a greater extent m male than m female DOC-salt-hypertensive rats Receptors for the gonadal steroid hormones are also found in centers m the brain involved m vasopressm release. 17~8 However, although vasopressm is essential for the production of DOC-salt hy- pertensron,J9~20 and although plasma levels of vasopressm are elevated m the hypertensive ammals,z-4 differences m plasma levels of vasopressm are not responsible for the gender-dependent difference m the development of the hypertensron or the effects of gonadectomy on that development, since plasma vasopressm concentrations m DOC-salt-hypertensive rats were unaffected by either gender or gonadectomy 2-4 DOC-salt hypertension IS dependent on both the vasoconstrictor and antidmrettc actions of vasopressm, medtated by V, and V2 receptors, respectively Thus, DOC-salt hypertension is reduced by treatment with either V, or V2 receptor antagomsts. 16~9,~~ Indeed, chrome combmed treatment with V, and V2 antagonists almost completely prevented the development of the hypertension.21 It IS likely that estrogen attenuates thts form of hypertension by reducmg the pressor and antrdiurettc actions of vasopressm Both of these actions of vasopressm are greater m male than m female rats m the nonestrous phases of the estrous cycle,3Z22J4 and both of these gender differences are dependent on estrogen.25.26
The mechanisms by which estrogen attenuates the pressor response to vasopressin are uncertain One possibiltty is that estrogen, by means of its actions on centers m the bram Involved m cardtovascular regulation, can decrease the gain of the baroreceptor reflex. Indeed, we have found (Y -X Wang, unpublished observations, 1996) that the sensrtivtty of the heart rate component of the baroreceptor reflex IS greater m nonestrous female rats than m males There is also constderable evidence that estrogen can act directly on the vasculature to modify the response to vasoacttve agents, but the nature of this response is controversral On the one hand, acute treatment with 17&estradiol decreased the contractrle response of rat tail artery strrps to vasopressm 27 On the other hand, treatment of intact female rats with estradiol, compared with untreated ovanectomrzed rats, resulted m an increase m the vasoconstrrctor action of vasopressm m the isolated perfused mesentertc vascular bed.28
It is hkely that estrogen attenuates the anttdmretic action of vasopressm by a direct action on the collectmg duct V2 receptor density and the ability of vasopressm to stimulate CAMP synthesis are lower m renal collectmg duct cells obtamed from female than from male rats,29 and m cultured renal medullary cells, estradiol decreased the ability of vasopressm to stimulate CAMP productron ?O To the extent that increased activity of the sympathetic nervous system contributes to DOC-salt hypertension, modulation by estrogen of the vasoconstrictor action of catecholammes could contribute to the sexual dimorphism m DOC-salt hypertension, but here too the reports are controversial The vasoconstriction action of norepmephrme or phenylephrme was decreased by estradtol m rat aortrc rmgs3O and rat tar1 artery strips27 and was increased by estradrol m preparations of the rat mesenteric vascular bed.3'J2 In intact male rats, acute treatment with estradtol reduced the pressor response to norepmephrine 27
Another possibthty to be considered 1s that estradrol, by increasing hepatic synthesis of plasma proteins that could bmd DOC, could ameliorate DOC-salt hypertension by decreasing the bioavailabihty of DOC However, since the dose of DOC used m these experiments was greatly m excess, it seems highly unlikely that any increase m plasma bmdmg protein concentratton could have been sufficiently large to have had an impact on the course of the hypertension Our observation that gonadectomy m male rats attenuated DOC-salt hypertension and that this effect was reversed by treatment with testosterone indicates that testosterone m male rats exacerbates thts form of hypertension This effect cannot be due to modulation of the actions of vasopressm by testosterone, since gonadectomy m males was without effect on either the pressor or antidmretrc24 responses to vasopressm However, since mcreased acttvity of the sympathetic nervous system is a contrrbutmg factor to DOC-salt hypertension, testosterone may exac- erbate the hypertension by increasing the pressor response to catecholammes.33-35 It is perhaps not surprismg that chronic treatment of intact male rats with estradiol attenuated the development of DOC-salt hypertension. Many of the experiments demonstratmg a vascular action of estradiol were carried out m male rats27J2J6 mdmatmg that there are vascular estrogen receptors m male rats. Similarly, estrogen bmdmg was demonstrated m catecholamme-contammg neurons of the brain stem m male as well as m female rats.irJ2 If estradiol mcreased the synthesis of plasma proteins that bind testosterone, the avarlabihty of testosterone could have been decreased, and this could have attenuated the hypertension.
The farlure of testosterone to affect the development of DOC-salt hypertension in female rats suggests that they lack testosterone receptors m relevant sites m the vasculature or central nervous system
Body weight was lower m intact males and gonadectomrzed females chronically treated wtth estradrol than m untreated intact males and gonadectomized females, respectively Although the hypertension was attenuated m the estradiol-treated rats, we are unaware of data that support an influence of growth rate or body mass on the development or severity of hypertension m rats. Indeed, the body weight was higher m intact hypertensive females chronically treated with testosterone, but the development and severity of the hypertension was similar to that m untreated intact females Testosterone can be converted to estrogen m both male and female rats by the enzyme aromatase It is unlikely that this was a srgmficant factor m the responses to testosterone treatment m the hypertensive gonadectomrzed males Body weight drd not fall, whereas treatment with estradiol lowered body weight, and more importantly SBP was mcreased to levels seen m intact hypertensive males On the other hand, conversion of testosterone to estrogen could have been a factor m the failure of testosterone to exacerbate the hypertension m intact females Indeed, SBP was lower in the second week of the DOC-salt regimen m intact females treated with testosterone than m untreated females Progesterone alone had no effect on the development of DOC-salt hypertensron m ovariectomrzed rats However, when progesterone was given to ovariectomized rats m combmation with estradiol, the ameliorating action of estradrol on the hypertension was prevented for the first 2 weeks of the experiment The fall m SBP m the third week of the experiment to a level similar to that m intact hypertensive females was associated with a fall in salme mtake, m the preceding 2 weeks, salme intake was elevated due to the influence of the estradtol There does not, however, appear to be a direct relationship between salme Intake and the magnitude of DOC-salt hypertension. Thus, for example, treatment of gonadectomized female and intact male DOC-salt-hypertensive rats with estradiol attenuated the hypertension and increased saline intake. One can only speculate that the abiltty of progesterone to prevent transiently the amehoratmg action of estradiol on the hypertension may be due to an effect of progesterone on estrogen receptors or postreceptor events at sites involved in the development of DOC-salt hypertension
In conclusron, the gender drfference m the development of DOC-salt hypertenston m the rat can be attributed to the gonadal steroid hormones Estrogen attenuates the hypertensron, whereas, m male rats, testosterone exacerbates the hypertension It seems hkely that the effects of estrogen result at least m part from modulation of the antidiuretrc and pressor actions of vasopressin, both of which contribute importantly to DOC-salt hypertension It is possible that the effects of testosterone on the hypertension, as well as, m part, the effects of estrogen, result from modulatron of the sympathetic nervous system, at the level of the central nervous system or the vasculature
